Zdrowie i gospodarka · 29/04/2002

FDA Advisory Committee to Discuss Biological Response Modifiers

The Biological Response Modifiers Advisory Committee of the Food and Drug Administration will hold a meeting on May 9-10, 2002, to provide advice on FDA's regulatory issues, including updates on research programs in therapeutic proteins and monoclonal antibodies.